Joseph A. Fraietta, Ph.D.
Affiliations: | 2012 | Drexel University College of Medicine, Philadelphia, PA, United States |
Area:
HIV, CD8 T cellGoogle:
"Joseph Fraietta"Mean distance: 20037.4
Parents
Sign in to add mentorPeter D. Katsikis | grad student | 2012 | Drexel Medical School | |
(Targeting Inflammation for the Prevention of Human Immunodeficiency Virus (HIV) Transmission and Disease Progression.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Myers RM, Devine KJ, Li Y, et al. (2024) Reinfusion of CD19 CAR T Cells for Relapse Prevention and Treatment in Children with Acute Lymphoblastic Leukemia. Blood Advances |
Ghilardi G, Fraietta JA, Gerson JN, et al. (2024) T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy. Nature Medicine |
Mackall C, Doan A, Mueller K, et al. (2023) FOXO1 is a master regulator of CAR T memory programming. Research Square |
Agarwal S, Aznar MA, Rech AJ, et al. (2023) Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells. Immunity. 56: 2388-2407.e9 |
Noll JH, Levine BL, June CH, et al. (2023) Beyond youth: Understanding CAR T cell fitness in the context of immunological aging. Seminars in Immunology. 70: 101840 |
Collins SM, Alexander KA, Lundh S, et al. (2023) TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells. Science Advances. 9: eadh2605 |
Jung IY, Noguera-Ortega E, Bartoszek R, et al. (2023) Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors. Cell Reports. Medicine. 101053 |
Jung IY, Bartoszek RL, Rech AJ, et al. (2023) Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T cell-intrinsic Dysfunction. Cancer Discovery |
Collins MA, Jung IY, Zhao Z, et al. (2022) Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL. Cancer Research Communications. 2: 1089-1103 |
Melenhorst JJ, Chen GM, Wang M, et al. (2022) Author Correction: Decade-long leukaemia remissions with persistence of CD4 CAR T cells. Nature |